Suny Koswara Rahajeng
STIKes Widya Dharma Husada Tangerang

Published : 15 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 15 Documents
Search

PROFIL PRESEPAN OBAT PADA PASIEN PEMBESARAN PROSTAT JINAK ATAU BPH (BENIGN PROSTATIC HYPERPLASIA) TAMSULOSIN DAN DUTASTERIDE DI INSTALASI RAWAT JALAN RUMAH SAKIT “X” CIPUTAT PERIODE OKTOBER-DESEMBER 2024 Dewantoro, Agung; Dewi, Bheta Sari; Rahajeng, Suny Koswara
PHRASE (Pharmaceutical Science) Journal Vol 5, No 1 (2025): Vol 5 No 1 : Pharmaceutical Science Journal
Publisher : Sekolah Tinggi Ilmu Kesehatan Widya Dharma Husada Tangerang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52031/phrase.v5i1.1003

Abstract

Benign prostatic hyperplasia (BPH) is a term used in histopathology to describe the presence of enlarged stromal and epithelial cells in the prostate gland.  In essence, BPH mostly affects elderly men whose testes are still capable of making testosterone. According to earlier research, using dutasteride and tamsulosin together may have greater therapeutic results for BPH and significantly lower the chance that symptoms may worsen. Purpose:  The objective of this study was to identify salient features of Tamsulosin and Dutasteride prescriptions for benign prostatic enlargement (BPH) at Ciputat "X" Hospital's outpatient clinic from October to December 2024.. Methods: This research method is descriptive, the data is taken restropectively, namely research that looks back, meaning data collection from medical records of outpatients with BPH diagnoses. Results: This study showed that, 101 samples of BPH patients were obtained, the most BPH patients occurred at the age of 56-65 (47.5%), the most work status was self-employed (44.6%), the mosttypes oftherapy were combination therapy oftamsulosin with dutasteride (56.4%), α1-blocker drug classes that got a percentage (100%), the most length of therapy was 1 month (98.0%), and other groups of drugs prescribed Antibiotics (37.5%).
PROFIL PERESEPAN OBAT ANTI TUBERKULOSIS PADA PASIEN ANAK DI INSTALASI FARMASI RAWAT JALAN RUMAH SAKIT X BOGOR PERIODE JANUARI – MARET 2023 Dewantoro, Agung; Andriati, Riris; Haryani, Setianti; Sakinah, Nur; Dewi, Bheta Sari; Rahajeng, Suny Koswara; Ismaya, Nurwulan Adi
PHRASE (Pharmaceutical Science) Journal Vol 3, No 2 (2023): Pharmaceutical Science Journal Vol 3 No 2, 2023
Publisher : Sekolah Tinggi Ilmu Kesehatan Widya Dharma Husada Tangerang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52031/phrase.v3i2.609

Abstract

Childhood tuberculosis is a disease caused by Mycobacterium tuberculosis at the age of 0-11 years. In Indonesia, tuberculosis is the third leading cause of death after cardiovascular disease and respiratory disease in all age groups. Tuberculosis in children is the most important factor in developing countries because the number of children aged 15 years is 40-50% of the total population. Objective: To find out the Prescribing Profile of Anti-Tuberculosis Drugs in Pediatric Patients at the Bogor X  Hospital Outpatient Pharmacy Installation for the January – March 2023 period. Methods: The type of research conducted was a non-experimental study with a descriptive research design. This research method was carried out using a quantitative approach and retrospective data collection. The retrospective approach is a study that looks backwards, which means collecting data from medical records with a diagnosis of tuberculosis. Results: This study showed that of the 94 tuberculosis patients at Bogor X  Hospital, the dominant sex was male (55.4%), with an age range of 0-5 years (65.9%), with an anatomical location of the disease in pulmonary tuberculosis (91.4%), with treatment for 6 months (95.7%) with comorbid dyspepsia (29.6%), with an intensive treatment phase, namely anti-tuberculosis drugs (66%), with an advanced treatment phase, namely anti-tuberculosis drugs (72.8%) and the use of other drugs, namely vitamins (72.8%).
UPAYA PENINGKATAN PENGETAHUAN KEPADA MASYARAKAT TERHADAP DAGUSIBU (DAPATKAN, GUNAKAN, SIMPAN, BUANG) OBAT Neneng Sri Purwaningsih; Beny Maulana Satria; Bheta Sari Dewi; Suny Koswara Rahajeng; Aulia Nadya Rizki Imansari; Anis Dwi Kristiyowati; Firdha Senja Maelaningsih
Jurnal Pengabdian IKIFA Vol. 4 No. 1 (2025): Jurnal Pengabdian IKIFA
Publisher : Sekolah Tinggi Ilmu Kesehatan IKIFA

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

One of the drug-related problems that is still widely found in society is drug abuse. Drug abuse that often occurs includes discovery of counterfeit drugs, drug trafficking, and the use of other dangerous substances. This happens because one of the factors is a lack of knowledge regarding drug management. Good drug management can be implemented through Dagusibu (Get, Use, Store, Dispose) Drugs. Therefore, it is necessary to provide community service in the form of Dagusibu Drug education to the community. The method used in this community service activity is the participatory community empowerment method with the Partipatory Rural Appreciation (PRA) model, which emphasizes community involvement in all activities carried out with direct outreach techniques to the community. The aim of this activity is to provide information and increase knowledge about Dagusibu Medicine to the community on Jl. Bakti Jaya Luk, Bakti Jaya Village, Setu District, South Tangerang City. Community service was carried out on May 8, 2024, and was attended by 23 participants. The result of this community service activity was an increase in public knowledge Obtaining, Using, Storing, and Disposing of (Dagusibu) medicines correctly, so that rational use of medicines will be realized and there will be no drug abuse.
Evaluasi Pemberian Informasi Obat Pada Pasien Tuberkulosis Di Rumah Sakit X Periode April 2025 Dewantoro, Agung; Haryani, Setianti; Rahajeng, Suny Koswara
PHRASE (Pharmaceutical Science) Journal Vol 5, No 2 (2025): Pharmaceutical Science Journal Vol 5 No 2, 2025
Publisher : Sekolah Tinggi Ilmu Kesehatan Widya Dharma Husada Tangerang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52031/phrase.v5i2.1083

Abstract

Drug Information Service (PIO) plays a crucial role in treatment success because accurate and precise information regarding drug use greatly supports the effectiveness of therapy. The objective of this study was to evaluate the provision of drug information to TB patients at Hospital X. Methods: This research used a quantitative descriptive design. Data were collected through a questionnaire distributed to 100 respondents selected using an accidental sampling technique based on predetermined inclusion criteria. Results : Treatment duration 4 months 61 respondents (61%), TB anatomical location pulmonary TB 100 respondents (100%), Treatment phase continuation phase 61 respondents (61%), Most commonly prescribed additional drug group vitamins (45.45%), Most commonly prescribed additional drug type Kurkumax on 40 respondent (40%), The provision of PIO services for TB patients at Hospital X was found to be in good condition (91%). Conclusion: The process of providing anti-tuberculosis drug information at Hospital X is categorized as good.
Profil Pengobatan Dan Efektivitas Obat Tuberkulosis Paru Pada Pasien Tuberkulosis Paru Di Puskesmas Kebayoran Lama Rahajeng, Suny Koswara; Sayyidah, Sayyidah; Fadhilah, Humaira; Dewantoro, Agung; Dewi, Bheta Sari; Ardiansyah, Muhammad Rivan
PHRASE (Pharmaceutical Science) Journal Vol 5, No 2 (2025): Pharmaceutical Science Journal Vol 5 No 2, 2025
Publisher : Sekolah Tinggi Ilmu Kesehatan Widya Dharma Husada Tangerang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52031/phrase.v5i2.1180

Abstract

Pulmonary tuberculosis (TB) is a serious health problem in Indonesia. A treatment profile that meets guidelines and patient compliance is crucial for successful therapy. To determine the treatment profile and effectiveness of TB drugs in patients at the Kebayoran Lama Community Health Center. This descriptive study used secondary data from the medical records of 78 pulmonary TB patients selected by purposive sampling from July to December 2024. Analysis was based on patient characteristics, treatment profiles, and drug effectiveness. The results the majority of patients were aged 17-25 years (38%), female (51%), had a high school education (54%), and worked as private sector workers (27%). In the intensive phase, most patients (72%) weighing 55-70 kg received a regimen of 4 tablets of 4FDC; the continuation phase used 4 tablets of 2FDC. The effectiveness of therapy was demonstrated by 54% of patients with negative AFB conversion accompanied by clinical improvement (reduced cough, increased appetite, decreased shortness of breath). The Conclusion is Pulmonary TB treatment at the Kebayoran Lama Community Health Center is in accordance with national guidelines with weight-based dosage. Regular evaluation is still needed to improve the success of therapy.